FDA Recalls More Metformin Extended-Release Tablets FDA Recalls More Metformin Extended-Release Tablets

Two lots of metformin HCl extended-release tablets have been recalled by Viona Pharmaceuticals because unacceptable levels of nitrosodimethylamine, a likely carcinogen, were found in the 750-mg tablets.News Alerts
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Alert Source Type: news